Skip to content

H.R. 1539 · 119th Congress (2025–2027)

Medical Device Electronic Labeling Act

This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container).

(Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.)

Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations.

The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1539’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Jay Obernolte (R-CA-23)
Cosponsors
7 cosponsors

3 original · 4 later

3 R · 4 D

  1. Rep. Angie Craig (D-MN-2)· Original · Feb 24, 2025
  2. Rep. Dan Crenshaw (R-TX-2)· Original · Feb 24, 2025
  3. Rep. Kevin Mullin (D-CA-15)· Original · Feb 24, 2025
  4. Rep. Scott H. Peters (D-CA-50)· Later · Apr 8, 2025
  5. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Apr 28, 2025
  6. Rep. Gus M. Bilirakis (R-FL-12)· Later · May 6, 2025
  7. Rep. Josh Gottheimer (D-NJ-5)· Later · Mar 24, 2026
Policy area
Health
Subjects
  • Computers and information technology
  • Consumer affairs
  • Drug safety, medical device, and laboratory regulation

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 24, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Medical Device Electronic Labeling Act

    Display title, Short title · Introduced in House

  2. To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.

    Official title · Introduced in House